Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase

Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase
Ebos CEO John Cullity doesn't want to pre-empt regulators. (Image: supplied)
Jenny Ruth
Ebos Group's purchase of the LifeHealthcare business is unlikely to have trouble clearing competition watchdogs on either side of the Tasman since its existing medical devices business is quite small.Ebos bought the LMT and National Surgical businesses in late 2019 for A$34 million compared with the LifeHealthcare purchase price of A$1.17 billion.In August last year, it also announced the purchase of Pioneer Medical, a New Zealand-based importer and distributor of spine and major joint implants and associated surgical technologies.Ebos didn...

More Infrastructure

The Great Expectations on Kāinga Ora and KiwiRail
Policy

The Great Expectations on Kāinga Ora and KiwiRail

The Government is continuing to refresh boards and fire up expectations.

Dileepa Fonseka 03 Jul 2024
Port of Tauranga a 'slow follower' on price hikes
Infrastructure

Port of Tauranga a 'slow follower' on price hikes

Forsyth Barr has upgraded its outlook from 'neutral' to 'outperform'.

Oliver Lewis 03 Jul 2024
Manukau Harbour port study takes its sweet time
Infrastructure

Manukau Harbour port study takes its sweet time

Winston called it ludicrous. Now it's late.

Oliver Lewis 02 Jul 2024